Search Results 781-790 of 24242 for In situ

  1. Surgery - Clinical trials

    ... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ, Lobular ...

  3. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: COVID-19 trials pause over safety concerns featured image · Aging · Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ ...

  4. A Dose Escalation Study of Amivantamab in Participants with Advanced Non-Small Cell Lung Cancer - Mayo Clinic

    ... in situ of the cervix, or malignancy that in the opinion of the investigator, with concurrence with the sponsor's medical monitor, is considered cured with ...

  5. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: COVID-19 trials pause over safety concerns featured image · Aging · Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ ...

  6. Medical Research & Education - Mayo Clinic News Network

    Aging · Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ vaccine featured image · Mayo Clinic Q&A podcast: US coronavirus map — what do the ...

  7. Follicular lymphoma - Symptoms and causes - Mayo Clinic

    In situ follicular B-cell neoplasm. Duodenal-type follicular lymphoma. Pediatric-type follicular lymphoma. Symptoms. Follicular lymphoma grows slowly and may ...

  8. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    ... in situ, patency needs to be confirmed before study start). Additionally, for Part 1 only: Patients: for whom there are no available standard of care ...

  9. Publications - Anagha Bangalore Kumar, M.B.B.S. - Mayo Clinic

    Bangalore Kumar A, Asamoah E, Baum CL. Retrospective Pilot Study: Squamous Cell Carcinoma in Situ of the Head and Neck Treated With Topical 5-Fluorouracil.

  10. Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... in this protocol, as referenced in the ICF. Exclusion Criteria: Subject has ... situ of the cervix, or breast, or other non-invasive lesion, that in ...